Unknown

Dataset Information

0

Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on "Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study".

ABSTRACT:

SUBMITTER: Zhu Y 

PROVIDER: S-EPMC11540366 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on "Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study".

Zhu Yixuan Y   Ma Xiaoyan X   Ni Wenjing W   Yeo Yee Hui YH   Shi Junping J   Li Jie J  

Clinical and molecular hepatology 20240704 4

Similar Datasets

Unknown Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease.
| S-EPMC12081649 | biostudies-literature
Unknown Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease
| S-SCDT-10_1038-S44321-025-00224-4 | biostudies-other
Unknown Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study.
| S-EPMC11016478 | biostudies-literature
Unknown Severity and Remission of Metabolic Dysfunction-Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence.
| S-EPMC10944048 | biostudies-literature
Unknown MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on "Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study".
| S-EPMC12016583 | biostudies-literature
Unknown Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease.
| S-EPMC12276452 | biostudies-literature
Unknown Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease.
| S-EPMC11240192 | biostudies-literature
Unknown Therapeutic management of metabolic dysfunction associated steatotic liver disease.
| S-EPMC10954426 | biostudies-literature
Transcriptomics Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease
2025-03-04 | GSE286394 | GEO
Unknown Differences in major adverse cardiovascular events of metabolic dysfunction-associated steatotic liver disease by race and ethnicity: Letter to the editor on "Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study".
| S-EPMC11540368 | biostudies-literature